Trending Articles

FDA panel, after debate, narrowly backs Merck COVID pill

Bio Pharma Dive

While agency advisers raised concerns over molnupiravir's modest benefits and potential risks, a majority felt the antiviral drug is a needed option for COVID-19 patients at high risk of severe disease

Drugs 215

There are instances when TV (DTC) is NOT a good idea

World of DTC Marketing

OPENING: TV is great at creating awareness, but it can also scare patients away if one of your side effects is “may lead to death.”

130
130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

New Merck study results raise questions about its COVID-19 pill

Bio Pharma Dive

Final trial data for molnupiravir were less convincing than what Merck previously reported and could alter how the FDA views the drug, which will be evaluated at a meeting Tuesday

Trials 279

The current pricing of cancer treatments is unsustainable

World of DTC Marketing

SUMMARY: The U.S. needs to take substantial steps to address the high costs of cancer drugs. From 2009 to 2019, the median monthly treatment costs for new drugs at launch reached $11,755 in the U.S… … Does the question become how much is a month(s) of other life worth?

An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space

Speaker: Steve Goldstein, Sales Leader

Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.

Biologic Therapeutics Development, Part 1: Definition and Distinct Characteristics

Camargo

The development of biological products (or biologics) represents a major advancement in modern medicine, enabling the treatment of patients with many illnesses where no other therapeutics were previously available.

CT uncovers bone disease in Tyrannosaurus rex jaw

Scienmag

Credit: RSNA and Charlie Hamm, M.D.

More Trending

Heart attacks struck Sek Kathiresan's family. He's devoted his life to stopping them.

Bio Pharma Dive

After several family members had early heart attacks, Kathiresan vowed to understand why they happen. His research journey has changed medical practice and led to a new biotech startup, Verve Therapeutics, that seeks to prevent them

Medscape vs. Doximity

World of DTC Marketing

SUMMARY: When it comes to reaching health care professionals, there is only one choice as far as I am concerned, and that’s Medscape. Working with them has always been a pleasure, and we can always “list match” targeted physicians.

Trial of Jazz’ cannabis drug in glioblastoma will start next year

Pharma Phorum

An investigator-led trial of Jazz Pharma’s cannabis extract-based drug Sativex in glioblastoma – an aggressive form of brain cancer – will get underway in the UK next year.

New computational approach predicts chemical reactions at high temperatures

Scienmag

New York, NY—December 1, 2021— Extracting metals from oxides at high temperatures is essential not only for producing metals such as steel but also for recycling.

Mandatory COVID Vaccination Policy Template

The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.

Early-Stage Diabetes Treatment Wows Patients and Clinicians Alike

BioSpace

In October, Vertex Pharmaceuticals announced stunning results in a type 1 diabetes patient who had been dosed with the company’s experimental therapy

97

FUJIFILM Irvine Scientific Establishes a Bioprocessing Innovation and Collaboration Center in China

BioTech 365

52

How far away is help? Researchers map access to HIV care

Scienmag

In sub-Saharan Africa, 7 million people with HIV live more than 10 minutes from health care services and 1.5

Omicron Variant has Vaccine Makers Moving Fast and More COVID News

BioSpace

Omicron has caused the U.S. to install travel bans against several South African countries while vaccine makers rush to test their vaccines against it. For that news and more, continue reading

With safety a concern, Merck, Gilead pause study of HIV drugs

Bio Pharma Dive

Out of an "abundance of caution," the companies halted enrollment in a trial evaluating the combination of Merck's islatravir and Gilead's lenacapavir

Trials 217

Healthy Tips

Riverside Clinical Research

Healthy living can lead to better living and improved overall quality of life. Who doesn’t want that? So, here are some tips to help you acquire a healthy lifestyle, beginning with nutrition and exercise which play a starring role in health management. Nutrition.

52

Westinghouse and EDF Collaborate in Life-Saving Nuclear Medical Applications

BioTech 365

52

New algorithm efficiently diagnoses shale fracture results from fiber-optic data

Scienmag

The oil industry put fiber-optic sensing cables downhole to better understand why hydraulic fracturing doesn’t free trapped oil at expected rates in shale reservoirs, but the massive streams of information received are hard to analyze.

Emmes Announces Completion of Third ACTT Clinical Trial for COVID-19

Pharma Mirror

Rockville, Emmes today announced that it conducted the data and statistical analysis for the third iteration of the Adaptive COVID-19 Treatment Trial (ACTT-3), using its proprietary Advantage eClinical system.

52

Vertex, needing research spark, finds promising results in small study of kidney disease drug

Bio Pharma Dive

The biotech, which has been stung by recent clinical setbacks, plans to soon advance the medicine into late-stage testing

New COVID variant ‘may sidestep vaccine protection’

Pharma Phorum

A new variant of COVID-19 identified in Botswana with dozens of mutations is being watched closely, amid fears it could be resistant to the effect of currently-used vaccines.

FS Development Corp. II Announces Effectiveness of Registration Statement for Proposed Business Combination with Pardes Special Meeting Scheduled for December 23, 2021

BioTech 365

FS Development Corp. II Announces Effectiveness of Registration Statement for Proposed Business Combination with Pardes Special Meeting Scheduled for December 23, 2021 FS Development Corp.

52

Directional management of interface defects achieved in perovskite solar cells

Scienmag

Organic-inorganic halide perovskite materials have excellent optical capture capacity and carrier conductivity. Perovskite solar cells, with amazing power conversion efficiency, show great application prospects.

82

Medinfar awarded first ever CPhI Verified Certificate

Pharma Mirror

CPhI awards the first ever CPhI Verified certificate to Medinfar – an international pharmaceutical manufacturer of Rx, cosmetics, food supplements and veterinary products.

Blueprint, taking aim at larger drugmakers, becomes a biotech buyer

Bio Pharma Dive

A $250 million acquisition of startup Lengo Therapeutics has given Blueprint a lung cancer drug that could compete with medicines from Takeda and J&J

Drugs 174

New patent expiration for Glaxo Grp drug FLOVENT HFA

Drug Patent Watch

Annual Drug Patent Expirations for FLOVENT+HFA Flovent Hfa is a drug marketed by Glaxo Grp Ltd and is included in one NDA. It is available from four suppliers. There are…. The post New patent expiration for Glaxo Grp drug FLOVENT HFA appeared first on DrugPatentWatch - Make Better Decisions.

Medorion’s Health Behavior Software Wins Pfizer’s Vaccines Global Innovation Challenge

BioTech 365

52

Ultra-processed foods increase the risk of a second heart attack or stroke

Scienmag

Ultra-processed foods are a major public health concern for their potential adverse effects on health. Now a study by the Department of Epidemiology and Prevention of the I.R.C.C.S.

81

Development of Omicron-specific vaccines is under way

BioPharma Reporter

Moderna, BioNTech and Johnson & Johnson have all started developing Omicron-specific vaccines: among a wider response plan to the SARS-CoV-2 variant. Bio Developments

Vaccine makers move quickly to confront omicron threat

Bio Pharma Dive

Several companies, including Pfizer and Moderna, are already at work adapting their coronavirus shots to the newly identified variant, which experts worry could more readily evade vaccine protection

Sigilon Uncovers Possible Reason Behind Hemophilia A Trial Hold

BioSpace

Sigilon Therapeutics announced it may have discovered the reason why its experimental cell therapy treatment for severe hemophilia A was placed on clinical hold by the FDA

Notable and CicloMed Initiate Phase 1B/2A Clinical Trial of Fosciclopirox in Acute Myelogenous Leukemia Under Co-Development Agreement

BioTech 365

Forensic Sciences Research Volume 6, Issue 3 publishes

Scienmag

[link] Credit: FSR [link] Special Issue: Sharing Clinical and Forensic Toxicology Knowledge in the Era of a Pandemic and Beyond This special issue includes an editorial, one review, five research articles and two case reports from leading scientists in the field that further the discussion on clinical and forensic toxicology.

Will the Vaccines Stop Omicron? Scientists Are Racing to Find Out.

NY Times

A “Frankenstein mix” of mutations raises concerns, but the variant may remain vulnerable to current vaccines. If not, revisions will be necessary.

GSK hires away top Pfizer vaccine scientist

Bio Pharma Dive

Philip Dormitzer, who helped Pfizer develop shots for COVID-19, RSV and influenza, will become the British pharma's head of vaccine R&D next month